21
TITLE: Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer?
AUTHORS: Ramon Andrade de Mello; Jailson de Oliveira; Georgios Antoniou;
PUBLISHED: 2017, SOURCE: FUTURE ONCOLOGY, VOLUME: 13, ISSUE: 4
INDEXED IN: Scopus WOS
22
TITLE: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
AUTHORS: Aguiar, PN; Perry, LA; Penny Dimri, J; Babiker, H; Tadokoro, H; de Mello, RA; Lopes, GL;
PUBLISHED: 2017, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 28, ISSUE: 9
INDEXED IN: Scopus WOS
23
TITLE: MicroRNAs in lung cancer
AUTHORS: Diana Castro; Marcia Moreira; Alexandra Monteiro Gouveia ; Daniel Humberto Pozza ; Ramon Andrade De Mello;
PUBLISHED: 2017, SOURCE: ONCOTARGET, VOLUME: 8, ISSUE: 46
INDEXED IN: Scopus WOS CrossRef: 60
24
TITLE: The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer
AUTHORS: Ines Faleiro; Joana Dias Apolonio; Aryeh J Price; Ramon Andrade De Mello; Vania Palma Roberto; Uri Tabori; Pedro Castelo Branco;
PUBLISHED: 2017, SOURCE: FUTURE ONCOLOGY, VOLUME: 13, ISSUE: 23
INDEXED IN: Scopus WOS
25
TITLE: Comparative Outcome Assessment of EGFR TKIs for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis
AUTHORS: Ramon Andrade De Mello; Pedro Aguiar; Paloma Cabral; Fablo Chaves; Davi Liu; Joao Paulo Soares; Giannis Mountzios; Hakaru Tadokoro; Gilberto De Lima Lopes;
PUBLISHED: 2017, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 12, ISSUE: 1
INDEXED IN: WOS
26
TITLE: Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms
AUTHORS: Ines de Paula Monteiro; Raffaele Califano; Giannis Mountzios; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
27
TITLE: Current advances in targeted therapies for metastatic gastric cancer: improving patient care
AUTHORS: Pedro Nazareth Aguiar; Thiago Pimentel Muniz; Raelson Rodrigues Miranda; Hakaru Tadokoro; Nora Manoukian Forones; Ines de Paula Monteiro; Pedro Castelo Branco; Yelena Y Janjigian; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
28
TITLE: Are there, or shall we discover, biomarkers to guide PD-1 inhibition?
AUTHORS: Paolo A Ascierto; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: IMMUNOTHERAPY, VOLUME: 8, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
29
TITLE: TG4010 immunotherapy: a novel weapon against advanced non-small cell lung cancer?
AUTHORS: Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 4, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
30
TITLE: A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker
AUTHORS: Aguiar, PN; Santoro, IL; Tadokoro, H; Lopes, GD; Filardi, BA; Oliveira, P ; Castelo Branco, P; Mountzios, G; de Mello, RA;
PUBLISHED: 2016, SOURCE: Immunotherapy, VOLUME: 8, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
Page 3 of 6. Total results: 59.